Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.
Schizophr Bull
; 41(5): 1003-9, 2015 Sep.
Article
en En
| MEDLINE
| ID: mdl-25837304
Recent findings implicate alterations in glutamate signaling, leading to aberrant synaptic plasticity, in schizophrenia. Matrix metalloproteinase-9 (MMP-9) has been shown to regulate glutamate receptors, be regulated by glutamate at excitatory synapses, and modulate physiological and morphological synaptic plasticity. By means of functional gene polymorphism, gene responsiveness to antipsychotics and blood plasma levels MMP-9 has recently been implicated in schizophrenia. This commentary critically reviews these findings based on the hypothesis that MMP-9 contributes to pathological synaptic plasticity in schizophrenia.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Esquizofrenia
/
Receptores de Glutamato
/
Metaloproteinasa 9 de la Matriz
/
Plasticidad Neuronal
Límite:
Humans
Idioma:
En
Revista:
Schizophr Bull
Año:
2015
Tipo del documento:
Article
País de afiliación:
Polonia
Pais de publicación:
Estados Unidos